The Alte Schäfflerei at Benediktbeuern Monastery – Conjunction of Architectural Conservation and Energy Performance Improvement in a Historic Buildings
Kilian, R, Bichlmair, S, Krus, M, Merktle, D, Milch, C, Sedlbauer, K P
Published in IOP conference series. Earth and environmental science (01.10.2021)
Published in IOP conference series. Earth and environmental science (01.10.2021)
Get full text
Journal Article
943b Induction Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial
Feagan, B.G, Rutgeerts, P.J, Sands, B.E, Colombel, J, Sandborn, W.J, Hanauer, S.B, Van Assche, G.A, Axler, J, Kim, H, Danese, S, Fox, I, Milch, C, Sankoh, S, Wyant, T, Xu, J, Parikh, A
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2012)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2012)
Get full text
Journal Article
P471 A Transcriptome-dependent Prognostic Model of Response in Patients with Ulcerative Colitis
Johnson, T, Reinisch, W, Steere, B, Milch, C, Harris, C, Morris, N, D'Haens, G, Huang, K, Krishnan, V
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
P255 Mirikizumab modulates genes associated with the symptom of bowel urgency
Krishnan, G, Steere, B, Higgs, R, Wang, Y C, Harris, C J, Milch, C, Escobar, R, Reinisch, W, Dubinsky, M
Published in Journal of Crohn's and colitis (21.01.2022)
Published in Journal of Crohn's and colitis (21.01.2022)
Get full text
Journal Article
DOP86 Mirikizumab-induced upregulation of colonic transcripts correlates with improvements in stool frequency in a phase 2 study of patients with moderately to severely active Ulcerative Colitis
Steere, B, Powell, N, Higgs, R, Wang, Y C, Milch, C, Sandborn, W J, Sands, B E, Reinisch, W, D’Haens, G, Krishnan, G
Published in Journal of Crohn's and colitis (21.01.2022)
Published in Journal of Crohn's and colitis (21.01.2022)
Get full text
Journal Article
OP26 Efficacy and safety of mirikizumab as induction therapy in patients with moderately to severely active Ulcerative Colitis: Results from the Phase 3 LUCENT-1 study
D’Haens, G, Kobayashi, T, Morris, N, Lissoos, T, Hoover, A, Li, X, Arora, V, Milch, C, Sandborn, W J, Sands, B E
Published in Journal of Crohn's and colitis (21.01.2022)
Published in Journal of Crohn's and colitis (21.01.2022)
Get full text
Journal Article
OP28 Gene expression (GE) values in a phase 2 trial of mirikizumab in ulcerative colitis (UC) correlate better with histopathology (HP) than endoscopy (EN) and Mayo scores
Steere, B, GOTTLIEB, K, Schmitz, J, Higgs, R, Jia, B, Milch, C, Tuttle, J, Krishnan, V, Belin, R, Reinisch, W
Published in Journal of Crohn's and colitis (15.01.2020)
Published in Journal of Crohn's and colitis (15.01.2020)
Get full text
Journal Article
A185 SUSTAINED SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-2 MAINTENANCE TRIAL
Dignass, A, Danese, S, Matsuoka, K, Ferrante, M, Long, M, Redondo, I, Gibble, T H, Moses, R, Li, X, Morris, N, Milch, C, Abreu, M, Jones, J
Published in Journal of the Canadian Association of Gastroenterology (07.03.2023)
Published in Journal of the Canadian Association of Gastroenterology (07.03.2023)
Get full text
Journal Article
A184 EARLY SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-1 INDUCTION TRIAL
Danese, S, Dignass, A, Matsuoka, K, Ferrante, M, Long, M, Redondo, I, Gibble, T H, Moses, R, Morris, N, Li, X, Milch, C, Abreu, M, Jones, J
Published in Journal of the Canadian Association of Gastroenterology (07.03.2023)
Published in Journal of the Canadian Association of Gastroenterology (07.03.2023)
Get full text
Journal Article
489P - Food Effect Study of the Investigational Aurora a Kinase (AAK) Inhibitor MLN8237 (ALISERTIB) in Patients with Advanced Solid Tumors
Falchook, G.S., Zhou, X., Rosen, L.S., Venkatakrishnan, K., Kurzrock, R., Mahalingam, D., Goldman, J., Jung, J., Milch, C., Sarantopoulos, J.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Food Effect Study of the Investigational Aurora a Kinase (AAK) Inhibitor MLN8237 (ALISERTIB) in Patients with Advanced Solid Tumors
Falchook, G.S., Zhou, X., Rosen, L.S., Venkatakrishnan, K., Kurzrock, R., Mahalingam, D., Goldman, J., Jung, J., Milch, C., Sarantopoulos, J.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
DOP058 Pharmacokinetic and pharmacodynamic relationship and immunogenicity of vedolizumab in adults with inflammatory bowel disease: Additional results from the GEMINI 1 and 2 studies
Rosario, M., Wyant, T., Milch, C., Parikh, A., Feagan, B., Sandborn, W.J., Yang, H., Fox, I.
Published in Journal of Crohn's and colitis (01.02.2014)
Published in Journal of Crohn's and colitis (01.02.2014)
Get full text
Journal Article
Emerging Safety Profile of Vedolizumab: A novel, selective Integrin Inhibitor for the treatment of IBD: P-0025
Feagan, B, Leach, T, Milch, C, Parikh, A, Fox, I
Published in Inflammatory bowel diseases (01.12.2009)
Published in Inflammatory bowel diseases (01.12.2009)
Get full text
Journal Article
No association between vedolizumab exposure and serum JC virus levels
Parikh, A, Fedyk, E, Clifford, D, Berger, J, Sankoh, S, Paolino, J, Fox, I, Milch, C
Published in Inflammatory bowel diseases (01.01.2011)
Published in Inflammatory bowel diseases (01.01.2011)
Get full text
Journal Article
P323 Sustained therapeutic benefit of vedolizumab throughout 1 year in ulcerative colitis in GEMINI I, a randomized, placebo-controlled, double-blind, multicenter trial
Sandborn, W., Sands, B., Rutgeerts, P., Sankoh, S., Rosario, M., Milch, C., Fox, I.
Published in Journal of Crohn's and colitis (01.02.2013)
Published in Journal of Crohn's and colitis (01.02.2013)
Get full text
Journal Article
P234 Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers
Milch, C., Wyant, T., Xu, J., Kent, W., Berger, J., Fox, I.H.
Published in Journal of Crohn's and colitis (01.02.2012)
Published in Journal of Crohn's and colitis (01.02.2012)
Get full text
Journal Article
11 Vedolizumab induction therapy for patients with Crohn's disease and prior anti-tumour necrosis factor antagonist failure: a randomised, placebo-controlled, double-blind, multicentre trial
Sands, B., Feagan, B., Rutgeerts, P., Colombel, J.-F., Sandborn, W., Sy, R., D'Haens, G., Ben-Horin, S., Xu, J., Fox, I., Parikh, A., Milch, C., Hanauer, S.
Published in Journal of Crohn's and colitis (01.02.2013)
Published in Journal of Crohn's and colitis (01.02.2013)
Get full text
Journal Article
Gastrointestinal selectivity of vedolizumab (MLN0002), a humanized monoclonal antibody to the alpha4beta7 integrin: P-0025
Parikh, A, Fedyk, E, Soler, D, Wyant, T, Kadambi, V, Leach, T, Milch, C, Fox, I
Published in Inflammatory bowel diseases (01.12.2008)
Published in Inflammatory bowel diseases (01.12.2008)
Get full text
Journal Article